$ATVK
Ameritek Ventures, Inc.

2023 Q4 Form 10-Q Financial Statement

#000137647423000492 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $246.5K $186.3K $575.5K
YoY Change -67.62%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $140.0K $177.3K
YoY Change
% of Gross Profit
Research & Development $105.5K $547.6K
YoY Change -80.72%
% of Gross Profit
Depreciation & Amortization $11.90K $10.04K
YoY Change
% of Gross Profit
Operating Expenses $150.1K $187.4K $680.3K
YoY Change -72.46%
Operating Profit -$1.051K -$104.9K
YoY Change -99.0%
Interest Expense -$72.74K $37.71K $37.57K
YoY Change 0.37%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $23.69K -$38.76K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $23.69K -$38.76K $23.03K
YoY Change -268.32%
Net Earnings / Revenue 9.61% -20.8% 4.0%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 514.2M shares 514.2M shares 514.2M shares
Diluted Shares Outstanding 514.2M shares 514.2M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.620K $7.500K
YoY Change
Cash & Equivalents $5.618K $7.497K $1.256K
Short-Term Investments
Other Short-Term Assets $1.520K $1.520K
YoY Change
Inventory
Prepaid Expenses $1.519K $1.521K
Receivables $132.4K $74.94K
Other Receivables $0.00 $0.00
Total Short-Term Assets $139.5K $83.96K
YoY Change -62.92%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00
YoY Change
Goodwill $2.185M $2.185M
YoY Change
Intangibles
YoY Change
Long-Term Investments $661.9K $661.9K
YoY Change
Other Assets $35.11K $534.2K
YoY Change -98.74%
Total Long-Term Assets $3.656M $3.631M
YoY Change -1.28%
TOTAL ASSETS
Total Short-Term Assets $139.5K $83.96K
Total Long-Term Assets $3.656M $3.631M
Total Assets $3.795M $3.715M
YoY Change -6.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $987.1K $1.166M
YoY Change -17.12%
Accrued Expenses $547.2K $205.3K
YoY Change 28.2%
Deferred Revenue
YoY Change
Short-Term Debt $21.00K $21.00K
YoY Change 0.0%
Long-Term Debt Due $89.10K
YoY Change
Total Short-Term Liabilities $1.706M $1.910M
YoY Change -15.75%
LONG-TERM LIABILITIES
Long-Term Debt $1.933M $1.589M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.933M $1.589M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.706M $1.910M
Total Long-Term Liabilities $1.933M $1.589M
Total Liabilities $3.640M $3.499M
YoY Change -3.74%
SHAREHOLDERS EQUITY
Retained Earnings -$2.379M -$2.403M
YoY Change 2.54%
Common Stock $554.2K $514.2K
YoY Change 7.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $155.6K $215.8K
YoY Change
Total Liabilities & Shareholders Equity $3.795M $3.715M
YoY Change -6.97%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $23.69K -$38.76K $23.03K
YoY Change -268.32%
Depreciation, Depletion And Amortization $11.90K $10.04K
YoY Change
Cash From Operating Activities -$196.3K $17.87K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 194.4K -13.13K
YoY Change
NET CHANGE
Cash From Operating Activities -196.3K 17.87K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 194.4K -13.13K
Net Change In Cash -1.880K 4.740K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$196.3K $17.87K
Capital Expenditures $0.00
Free Cash Flow -$196.3K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54739
dei Entity Registrant Name
EntityRegistrantName
Ameritek Ventures, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2380777
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
1589386 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1755899 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
325 N Milwaukee Ave. Suite G1
dei Entity Address City Or Town
EntityAddressCityOrTown
Wheeling
CY2023Q3 us-gaap Liabilities
Liabilities
3498951 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3781262 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60090
dei Entity Address Address Description
EntityAddressAddressDescription
Address of principal executive offices
dei City Area Code
CityAreaCode
312
dei Local Phone Number
LocalPhoneNumber
239-3574
dei Phone Fax Number Description
PhoneFaxNumberDescription
Issuer’s telephone number
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
514226791 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7497 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
751 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
74943 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
374003 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1521 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1519 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
83961 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
376273 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
661886 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
661886 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
534162 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2791472 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2184715 usd
CY2022Q4 us-gaap Goodwill
Goodwill
0 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
3630763 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3703358 usd
CY2023Q3 us-gaap Assets
Assets
3714724 usd
CY2022Q4 us-gaap Assets
Assets
4079631 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1166295 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1191025 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
205270 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
426842 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
517000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
386496 usd
CY2023Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
21000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
21000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1909565 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2025363 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
514226791 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
514226791 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
514226791 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
514226791 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
514227 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
514227 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1239878 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1239878 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2402945 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2320349 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
215773 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
298369 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3714724 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4079631 usd
CY2023Q3 us-gaap Revenues
Revenues
186337 usd
CY2022Q3 us-gaap Revenues
Revenues
575466 usd
us-gaap Revenues
Revenues
702936 usd
us-gaap Revenues
Revenues
805240 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
105548 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
547560 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
406640 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
719339 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
71796 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
70123 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
193307 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
296054 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
0 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
9489 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
277 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
11854 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10044 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53174 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
72593 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
153782 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
187388 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
680346 usd
us-gaap Operating Expenses
OperatingExpenses
672817 usd
us-gaap Operating Expenses
OperatingExpenses
1181029 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1051 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-104880 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
30119 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-375789 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
165472 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
496414 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
37705 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
37567 usd
us-gaap Interest Expense
InterestExpense
112715 usd
us-gaap Interest Expense
InterestExpense
113823 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-38756 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
23025 usd
us-gaap Net Income Loss
NetIncomeLoss
-82596 usd
us-gaap Net Income Loss
NetIncomeLoss
6802 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
514226791 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
514226791 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
514226791 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
514226791 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
514226791 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
514226791 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
514226791 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
514226791 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
137627 usd
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
6802 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
138292 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
298369 usd
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-82596 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
215773 usd
us-gaap Profit Loss
ProfitLoss
-82596 usd
us-gaap Profit Loss
ProfitLoss
6802 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
72591 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
153781 usd
fil Sale Of Patent
SaleOfPatent
0 usd
fil Sale Of Patent
SaleOfPatent
496415 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-299060 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-141243 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-22778 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-24730 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
370813 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
90158 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
86822 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-181226 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-50933 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
173259 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
234891 usd
fil Product Development Expenditures
ProductDevelopmentExpenditures
0 usd
fil Product Development Expenditures
ProductDevelopmentExpenditures
-36071 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36071 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
28313 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
194826 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
226250 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-166513 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-226250 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6746 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27430 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
751 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28686 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7497 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1256 usd
us-gaap Interest Paid
InterestPaid
19286 usd
us-gaap Interest Paid
InterestPaid
1028 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
0 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
661887 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:9pt Times New Roman;margin-top:0pt;margin-bottom:10pt;margin-left:18pt"><kbd style="position:absolute;font:9pt Times New Roman;margin-left:-18pt"><b>1.</b></kbd><b>GENERAL ORGANIZATION AND BUSINESS</b> </p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">The Company was organized on December 27, 2010, under the laws of the State of Nevada, as ATVROCKN. On June 20, 2017, the Company changed its corporate name to Ameritek Ventures, Inc (“Ameritek Ventures” or “Ameritek” or the “Company”).</p> <p style="font:9pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">Ameritek is a group of companies that provides various world-class software and hardware products and services beneficial to businesses, organizations, and governments. We have an established presence in the warehouse solutions market. With Interactive Systems, Inc. we provide software inventory management and with interlinkONE, Inc. we provide SaaS cloud-based solutions for warehouse and inventory fulfillment. We manufacture and innovate advanced technological developments in the medical industry, such as the DittoMask high-filtration mask and FlexFridge portable mini-fridge for medical use. We also develop blockchain technology software programs under WebBeeO and CordTell companies. Furthermore, Ameritek Ventures explores augmented reality technology with Passley, Inc., and Augmum, Inc. Meanwhile, our vertical landing aircraft service from AeroPass, Inc. takes ZenaDrone technology to a higher level with members-only passenger first-class transport across cities. Ecker Capital, LLC, is our merger and acquisition division. The Company also recently created a new business, Equock, Inc., with which Ameritek will develop an electric bicycle with a focus on the growing online delivery industry.</p>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2010-12-27
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:9pt Times New Roman;margin:0;text-align:justify"><b>Use of Estimates</b></p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Advertising Expense
AdvertisingExpense
7165 usd
us-gaap Advertising Expense
AdvertisingExpense
35376 usd
CY2023Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7694 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7694 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
28568 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
28568 usd
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4200 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4200 usd
CY2023Q3 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
2783 usd
CY2022Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
2783 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43245 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43245 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43245 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43245 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43245 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43245 usd
CY2022Q4 fil Product Development Costs
ProductDevelopmentCosts
602722 usd
fil Product Development Addition
ProductDevelopmentAddition
0 usd
CY2023Q3 fil Product Development Costs
ProductDevelopmentCosts
602722 usd
CY2022Q4 fil Product Development Total Amortizatiion
ProductDevelopmentTotalAmortizatiion
38423 usd
fil Product Development Amortization
ProductDevelopmentAmortization
10045 usd
CY2023Q3 fil Product Development Total Amortizatiion
ProductDevelopmentTotalAmortizatiion
30136 usd
CY2023Q3 fil Product Development Net Book Value
ProductDevelopmentNetBookValue
534163 usd
us-gaap Debt Instrument Issuance Date1
DebtInstrumentIssuanceDate1
2021-05-13
us-gaap Debt Instrument Issuer
DebtInstrumentIssuer
Ameritek
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
185000 usd
us-gaap Debt Instrument Description
DebtInstrumentDescription
non-convertible promissory note
CY2023Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
23511 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2511 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
23167 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2167 usd
CY2023Q3 fil Promissory Notes Current And Non Current
PromissoryNotesCurrentAndNonCurrent
1589386 usd
CY2022Q4 fil Promissory Notes Current And Non Current
PromissoryNotesCurrentAndNonCurrent
1755899 usd
CY2023Q3 fil Promissory Notes Current
PromissoryNotesCurrent
0 usd
CY2022Q4 fil Promissory Notes Current
PromissoryNotesCurrent
0 usd
CY2023Q3 fil Promissory Notes Non Current
PromissoryNotesNonCurrent
1589386 usd
CY2022Q4 fil Promissory Notes Non Current
PromissoryNotesNonCurrent
1755899 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
89097 usd
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
108383 usd
CY2022 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
424675 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
514226791 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
514226791 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
514226791 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
514226791 shares
us-gaap Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
May 6, 2019
us-gaap Loss Contingency Actions Taken By Plaintiff
LossContingencyActionsTakenByPlaintiff
Meridian Pacific Holdings, LLC filed a lawsuit against certain directors, officers, affiliates, and the Company
us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
Meridian Pacific Holdings, LLC
us-gaap Loss Contingency Allegations
LossContingencyAllegations
breach of contract and fraud
us-gaap Loss Contingency Domicile Of Litigation
LossContingencyDomicileOfLitigation
Superior Court of the State of California, County of Los Angeles
us-gaap Gain Contingency Description
GainContingencyDescription
On March 6, 2023, the Company filed a lawsuit in the Clark County, Nevada, court against Clinton L. Stokes, III, the former owner of the Company, to settle the matter of shares ownership
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
661887 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
661887 usd
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
661887 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0 usd
CY2019Q2 us-gaap Subsequent Events Date
SubsequentEventsDate
2019-05-06
CY2019Q2 us-gaap Subsequent Event Description
SubsequentEventDescription
Meridian Pacific Holdings, LLC filed a lawsuit against certain directors, officers, affiliates, and the Company for breach of contract and fraud, in the Superior Court of the State of California, County of Los Angeles
CY2023Q4 us-gaap Subsequent Events Date
SubsequentEventsDate
2023-10-19
CY2023Q4 us-gaap Subsequent Event Description
SubsequentEventDescription
the judge in this case dismissed all claims against Ameritek Ventures, Inc.

Files In Submission

Name View Source Status
0001376474-23-000492-index-headers.html Edgar Link pending
0001376474-23-000492-index.html Edgar Link pending
0001376474-23-000492.txt Edgar Link pending
0001376474-23-000492-xbrl.zip Edgar Link pending
atvk-20230930.htm Edgar Link pending
atvk-20230930.xsd Edgar Link pending
av_ex31z1.htm Edgar Link pending
atvk-20230930_cal.xml Edgar Link unprocessable
atvk-20230930_def.xml Edgar Link unprocessable
atvk-20230930_lab.xml Edgar Link unprocessable
atvk-20230930_pre.xml Edgar Link unprocessable
atvk-20230930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
av_ex31z2.htm Edgar Link pending
av_ex32z1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending